| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
disease | 0.100 | None | 0.961 | 127 | 1 | 1975 | 2019 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.360 | None | 1.000 | 6 | 0 | 1980 | 2017 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.700 | None | 0.968 | 2989 | 40 | 1981 | 2020 | ||||||||
|
lactalbumin alpha | 0.729 | 0.423 | 0.46 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1981 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.900 | None | 0.971 | 1178 | 43 | 1982 | 2020 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 11 | 1 | 1983 | 2017 | ||||||||
|
trefoil factor 1 | 0.529 | 0.769 | 8.9E-04 |
|
disease | 0.100 | None | 1.000 | 36 | 0 | 1984 | 2018 | ||||||||
|
presenilin 2 | 0.550 | 0.654 | 5.4E-04 |
|
disease | 0.100 | None | 1.000 | 23 | 1 | 1984 | 2017 | ||||||||
|
taste 2 receptor member 64 pseudogene | 0.678 | 0.385 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 1984 | 2017 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 1984 | 2020 | |||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
disease | 0.400 | None | 0.936 | 579 | 18 | 1985 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.980 | 202 | 1 | 1985 | 2019 | ||||||||
|
sex hormone binding globulin | 0.438 | 0.808 | 1.3E-06 |
|
disease | 0.100 | None | 0.925 | 40 | 2 | 1985 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.100 | None | 0.960 | 25 | 1 | 1985 | 2019 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
disease | 0.390 | None | 0.900 | 9 | 1 | 1985 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.400 | None | 0.959 | 220 | 5 | 1986 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.978 | 139 | 1 | 1986 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.600 | None | 0.919 | 33 | 0 | 1986 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.600 | None | 0.972 | 4094 | 24 | 1987 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.974 | 564 | 13 | 1987 | 2020 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.100 | None | 1.000 | 47 | 0 | 1987 | 2019 | ||||||||
|
cathepsin D | 0.478 | 0.846 | 9.2E-04 |
|
disease | 0.100 | None | 0.978 | 45 | 0 | 1987 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.950 | 40 | 3 | 1987 | 2020 | ||||||||
|
prolactin receptor | 0.572 | 0.692 | 0.99 |
|
disease | 0.100 | None | 1.000 | 38 | 4 | 1987 | 2019 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.100 | None | 0.966 | 29 | 0 | 1987 | 2018 |